RIASTAP 1 g, powder for solution for injection/infusion bottle
Active ingredients: FIBRINOGÈNE HUMAIN
Commercialized according to BDPMDispensing in France: Prescription only
Powder for solution for injection or infusionbottleintraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- RIASTAP 1 g, poudre pour solution injectable/perfusion
- Pharmaceutical form
- poudre pour solution injectable ou pour perfusion
- Route of administration
- intraveineuse
- Presentation description
- 1 flacon(s) en verre muni d'un bouchon sans latex (caoutchouc bromobutyle), serti d'une capsule en aluminium surmontée d'un disque en plastique avec 1 filtre et 1 dispositif de prélèvement
- Marketing authorisation holder
- CSL BEHRING (ALLEMAGNE)
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 19 Aug 2011
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Prescribed by a hospital doctor
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
61179660CIP74948842CIP133400949488421Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| FIBRINOGÈNE HUMAINpoudre | 1 g · un flacon | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.